Chief Medical Officer · ZEVRA THERAPEUTICS, INC. · ZEVRA THERAPEUTICS, INC. — Restricted Stock Unit
Side
A
Value
—
Shares
37.5K
Price
—
Executed
Jan 29, 2026
Disclosed
Feb 2, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Jan 29 executedFeb 2, 2026 disclosed
ZVRA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Quartel Adrian W filed this Form 4 reporting a grant or award of ZVRA on Jan 29, 2026. It became public on Feb 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Medical Officer
Quartel Adrian Wcik:0001910132
Issuer
ZEVRA THERAPEUTICS, INC.cik:0001434647
Revision history · 0
No field has changed since this record was first ingested.
